at one of the leading cancer research centers in the United States showing that the Company's lead drug candidate Escozine(R) caused up to 95 percent Specific Induced Apoptosis (SIA) in various types of Leukemia cancer cells. Such a result is significant not only to the Company's ongoing clinical research, but could have tremendous effects on cancer treatments worldwide.
News 
Market Data 
Discover 
AI
